Tissue Transplantation
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
Cell-mediated Immune Responses
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 4, 2025

A Human Cerebral Organoid Model of Neural Cell Transplantation
Published on: July 21, 2023
Andrea Peloso1,2, Beat Moeckli1,2, Vaihere Delaune1
1Department of General Surgery, University of Geneva Hospitals, University of Geneva, Geneva, Switzerland.
This review explores how computer-based intelligence systems might transform the field of organ transplantation by improving how organs are matched, monitored, and managed to increase patient survival rates.
Area of Science:
Background:
No prior work has fully synthesized the emerging role of machine-based decision systems within the complex landscape of organ replacement therapy. Prior research has shown that clinical data management remains a significant challenge for transplant teams worldwide. That uncertainty drove the need to evaluate how advanced computational tools might assist in high-stakes medical environments. It was already known that automated algorithms excel at pattern recognition in medical imaging and large datasets. This gap motivated a comprehensive look at how these technologies integrate into existing surgical workflows. Researchers have long sought better ways to predict graft outcomes and optimize long-term patient care. The rapid evolution of digital health tools now allows for more sophisticated analysis than previously possible. This review addresses the current state of these innovations to provide a clear picture of their potential impact.
Purpose Of The Study:
The aim of this review is to provide a comprehensive overview of how machine-based computational approaches are currently being applied in solid organ transplantation. The authors seek to address the growing need for digital solutions in complex clinical decision-making. They identify a specific problem regarding the limitations of human-only analysis in high-stakes transplant scenarios. The motivation for this work stems from the rapid evolution of digital health tools in other medical specialties. The researchers intend to clarify how these innovations can be adapted for the unique requirements of organ replacement. They highlight the potential for these systems to solve persistent challenges in donor matching and long-term patient monitoring. This manuscript serves to inform the community about the current state and future possibilities of these technologies. The authors aim to demonstrate that these tools are ready to shape an exciting future for the field.
Main Methods:
Review Approach involved a systematic synthesis of current literature regarding machine-based computational applications in clinical surgery. The authors conducted a broad search to identify relevant studies focusing on digital decision-making tools. They categorized findings into four distinct areas to structure the analysis of existing evidence. This process prioritized peer-reviewed publications that demonstrate practical utility in medical settings. The team evaluated how various algorithms perform tasks traditionally handled by human experts. They examined the potential for these systems to integrate into existing hospital infrastructure. This methodology focused on identifying gaps where digital solutions could provide measurable improvements. The synthesis provides a structured overview of how these technologies are currently being tested in clinical environments.
Main Results:
Key Findings From the Literature indicate that digital algorithms can successfully facilitate four specific domains within the transplant process. The review highlights that improved allocation and donor-recipient matching are among the most promising applications for these systems. The authors report that automated analysis of pathology slides offers a significant opportunity for increasing diagnostic precision. They also find that dynamic adaptation of immunosuppression regimes is feasible through continuous data monitoring. The literature suggests that these technologies have the potential to enhance both graft and patient survival outcomes. The authors note that current implementations range from simple decision support to complex predictive modeling. They observe that these tools are already being applied to optimize transplant oncology workflows. The findings demonstrate that the field is currently at the threshold of widespread digital adoption.
Conclusions:
Synthesis and Implications suggest that the integration of machine learning will likely redefine standard practices across the entire transplant lifecycle. The authors propose that automated systems could significantly enhance the precision of donor-recipient matching protocols. They also highlight the potential for dynamic adjustment of medication dosages to prevent organ rejection more effectively. Furthermore, the review indicates that automated image analysis may improve the accuracy of diagnostic pathology reports. The researchers emphasize that these digital advancements are positioned to increase both graft longevity and overall patient survival. They conclude that the field is entering a transformative period characterized by increased reliance on data-driven decision support. The authors maintain that these tools will serve as a powerful supplement to clinical expertise rather than a replacement. Finally, the manuscript frames these developments as the start of a new era for the global transplantation community.
The researchers propose that these systems improve outcomes through four primary mechanisms: optimizing organ allocation, refining donor-recipient pairing, managing transplant oncology, and enabling precision pathology. These tools allow for dynamic adjustments to immunosuppression regimes, which helps maintain graft health more effectively than static protocols.
The authors identify smart matching algorithms as a key component for improving donor-recipient compatibility. Unlike traditional methods, these digital frameworks process vast datasets to predict long-term compatibility, thereby reducing the risk of organ rejection compared to standard manual selection processes.
The researchers state that high-quality, standardized data is a technical necessity for training these models. Without robust datasets, the algorithms cannot accurately perform complex tasks like image analysis or predictive modeling, which are required for clinical implementation compared to theoretical research applications.
The authors describe the role of automated pathology as a tool for rapid, objective tissue evaluation. This data type allows for more consistent diagnostic results, which contrasts with the subjective variability often observed in manual microscopic examinations performed by human pathologists.
The researchers note that real-time immunosuppression adaptation is a critical measurement of success. By continuously monitoring patient biomarkers, these systems can adjust drug levels dynamically, offering a more personalized approach than the fixed-dose schedules typically used in current clinical practice.
The authors imply that these innovations will lead to a new digital era in the field. They suggest that adopting these technologies will improve survival rates, representing a shift toward more precise, data-informed care compared to the traditional, intuition-based decision-making models currently in use.